Instem Signs Agreement with Integrated Nonclinical Development Solutions, Inc.; Becomes Exclusive Global Supplier of SEND Explorer®
CONSHOHOCKEN, PA - (BUSINESS WIRE) – July 29, 2016 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that it has reached an agreement with Integrated Nonclinical Development Solutions, Inc. (“INDS”) to market, sell and support its SEND Explorer solution worldwide.
July 8, 2016 - Study Design Coverage Expanded
Bio-Safety Laboratory Deploys Provantis Software Solution to Help Streamline Non-Clinical Evaluation Studies
June 21, 2016 - Provantis Selected to Automate Processes in the Research of Deadly Pathogens, Emerging Diseases and Bioterror Agents
June 21, 2016 - Instem to Showcase Solutions for Preclinical Study Management, SEND and Genetic Toxicology
June 9, 2016 - Massachusetts Based Biopharmaceutical Company Automates Histopathology Processes